APA

Chibaudel B., Lacave R., Lefevre M., Soussan P., Antoine M., Périé S., Belloc J., Banal A., Albert S., Chabolle F., Céruse P., Baril P., Gatineau M., Housset M., Moukoko R., Benetkiewicz M., de Gramont A., Bonnetain F. & Lacau St Guily J. (20160202). Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study. : Cancer medicine.

Chicago

Chibaudel Benoist, Lacave Roger, Lefevre Marine, Soussan Patrick, Antoine Martine, Périé Sophie, Belloc Jean-Baptiste, Banal Alain, Albert Sébastien, Chabolle Frédéric, Céruse Philippe, Baril Philippe, Gatineau Michel, Housset Martin, Moukoko Rachel, Benetkiewicz Magdalena, de Gramont Aimery, Bonnetain Franck and Lacau St Guily Jean. 20160202. Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study. : Cancer medicine.

Harvard

Chibaudel B., Lacave R., Lefevre M., Soussan P., Antoine M., Périé S., Belloc J., Banal A., Albert S., Chabolle F., Céruse P., Baril P., Gatineau M., Housset M., Moukoko R., Benetkiewicz M., de Gramont A., Bonnetain F. and Lacau St Guily J. (20160202). Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study. : Cancer medicine.

MLA

Chibaudel Benoist, Lacave Roger, Lefevre Marine, Soussan Patrick, Antoine Martine, Périé Sophie, Belloc Jean-Baptiste, Banal Alain, Albert Sébastien, Chabolle Frédéric, Céruse Philippe, Baril Philippe, Gatineau Michel, Housset Martin, Moukoko Rachel, Benetkiewicz Magdalena, de Gramont Aimery, Bonnetain Franck and Lacau St Guily Jean. Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study. : Cancer medicine. 20160202.